FAVOR III E-J Trial – Enrollment completed

2000 enrolled patients

2 mins – July 25, 2023

Congratulations to all the FAVOR III E-J sites across Europe for their dedicated efforts in enrolling 2000 patients for this very important trial! The 2000th patient was enrolled on July 21, 2023.
The FAVOR III E-J trial is a carefully designed and executed prospective, randomized, multi-center study comparing the Medis QFR® image-based coronary physiology solution applied in the on-line setting, versus the traditional wire-based FFR approach. It is the very first of ongoing non-inferiority trials that has completed its enrollment.
We are eagerly looking forward to the results of this exciting trial after the 1-year follow-up. Together with our users we continue our mission to drive medical innovation and strive for better healthcare for patients worldwide.
Once again, our sincere gratitude to all the FAVOR III E-J sites for all their efforts.

Share this article on:


All news

Interested in Medis QFR ®?

Easily request a demo of our innovative software solution

Request a demo

Sign up for our newsletter

Subscribe now to find out more about our solutions, latest publications and future releases.

By providing your information and continuing, you agree to Medis’ Terms of Use and Privacy Policy *